MARTINI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 1642
EU - Europa 1049
AS - Asia 657
SA - Sud America 47
AF - Africa 23
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3431
Nazione #
US - Stati Uniti d'America 1604
CN - Cina 420
IT - Italia 282
IE - Irlanda 111
SE - Svezia 106
FR - Francia 100
DE - Germania 92
AT - Austria 59
GB - Regno Unito 52
BE - Belgio 45
ES - Italia 38
KR - Corea 35
CA - Canada 31
JP - Giappone 31
UA - Ucraina 31
IN - India 30
TR - Turchia 29
VN - Vietnam 26
FI - Finlandia 22
NL - Olanda 19
EG - Egitto 18
PL - Polonia 18
AR - Argentina 16
BR - Brasile 13
PH - Filippine 12
PT - Portogallo 12
TH - Thailandia 12
CO - Colombia 11
HK - Hong Kong 11
GR - Grecia 10
RU - Federazione Russa 10
UZ - Uzbekistan 10
AU - Australia 9
RO - Romania 9
ID - Indonesia 7
SA - Arabia Saudita 7
MX - Messico 6
SG - Singapore 6
BA - Bosnia-Erzegovina 5
CH - Svizzera 5
DK - Danimarca 5
NO - Norvegia 5
PE - Perù 5
TW - Taiwan 5
IR - Iran 4
EU - Europa 3
MM - Myanmar 3
MY - Malesia 3
BY - Bielorussia 2
CL - Cile 2
CZ - Repubblica Ceca 2
EE - Estonia 2
HU - Ungheria 2
LT - Lituania 2
LU - Lussemburgo 2
SN - Senegal 2
BD - Bangladesh 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MA - Marocco 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
ZA - Sudafrica 1
Totale 3431
Città #
Chandler 358
Beijing 154
Dublin 111
Fairfield 103
Nyköping 75
Ann Arbor 70
Fremont 69
Torino 59
Vienna 56
Villeurbanne 53
Dearborn 49
Houston 48
Redwood City 48
Woodbridge 46
Cambridge 43
Medford 40
Wilmington 40
Princeton 39
Hangzhou 33
Ashburn 32
Brussels 29
Jacksonville 27
Pisa 21
Guangzhou 19
Hebei 19
Seattle 18
Rome 17
Milan 16
Shanghai 15
Turin 15
Warsaw 15
Nanjing 14
Dong Ket 13
Hanover 13
London 13
Paris 13
Berlin 11
Chengdu 11
Cairo 10
Chongqing 10
Tokyo 10
Toronto 10
Chicago 9
Boston 8
Seoul 8
Istanbul 7
Jakarta 7
Delhi 6
Gent 6
Jena 6
Kunming 6
Norwalk 6
Osaka 6
Ottawa 6
Rotterdam 6
San Diego 6
Upper Marlboro 6
Wuhan 6
Xian 6
Bordeaux 5
Buenos Aires 5
Bursa 5
Changsha 5
Diamond Bar 5
Duncan 5
Friedrichsdorf 5
Fuzhou 5
Hefei 5
Marsciano 5
Nanning 5
New York 5
Shenzhen 5
Tianjin 5
Yangsan 5
Bangalore 4
Barcelona 4
Bucharest 4
Buffalo 4
Central 4
Central District 4
Columbus 4
Eau Claire 4
Groningen 4
Hat Yai 4
Lima 4
Monza 4
Nanchang 4
Napoli 4
Padova 4
Ploce 4
Riyadh 4
San Francisco 4
Suri 4
Valdagno 4
Ankara 3
Atlanta 3
Badajoz 3
Battalgazi 3
Birmingham 3
Bloomfield Hills 3
Totale 2149
Nome #
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial 791
Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis 292
Extracellular Vesicles from Human Liver Stem Cells Reduce Injury in an Ex Vivo Normothermic Hypoxic Rat Liver Perfusion Model 258
Early reduced liver graft survival in hepatitis C recipients identified by two combined genetic markers 137
SOFOSBUVIR PLUS RIBAVIRIN IN PATIENTS WITH SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE 107
ALL ORAL SOFOSBUVIR-BASED ANTIVIRAL THERAPY IN LIVER TRANSPLANT RECIPIENTS AFFECTED BY MODERATE-SEVERE HEPATITIS C RECURRENCE: PREDICTORS OF VIRAL RESPONSE AND SURVIVAL 103
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: A real-life strategy 98
SOFOSBUVIR PLUS RIBAVIRIN BEFORE OR ACROSS LIVER TRANSPLANTATION TO PREVENT HCV RECURRENCE: A SINGLE CENTRE EXPERIENCE 96
Negativization of viremia prior to liver transplant reduces early allograft dysfunction in hepatitis C recipients 94
FEASIBILITY AND EFFICACY OF SOFOSBUVIR-BASED ANTIVIRAL THERAPY BEFORE LIVER TRANSPLANTATION TO PREVENT HCV RECURRENCE: A MONOCENTRIC EXPERIENCE 91
SOFOSBUVIR PLUS RIBAVIRIN FOR THE TREATMENT OF SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 90
Antiviral Therapy With Sofosbuvir Plus Ribavirin Before Or Across Liver Transplantation To Prevent HCV Recurrence: Preliminary Data from a Single Centre Experience 82
Carrying on with liver transplantation during the COVID-19 emergency: Report from Piedmont region 82
ANTIVIRAL THERAPY WITH SOFOSBUVIR PLUS RIBAVIRIN IN HCV-INFECTED CIRRHOTIC PATIENTS AWAITING LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 81
SAFETY AND EFFICACY OF SOFOSBUVIR-BASED ANTIVIRAL THERAPY IMMEDIATELY AFTER LIVER TRANSPLANTATION: A MATCHED CASE-CONTROL ANALYSIS 77
Successful urgent liver retransplantation for donor-transmitted hepatocellular carcinoma 76
Liver transplantation for patients with HCV-related end-stage liver disease and undetectable HCV-RNA: the Turin Centre experience 71
ANTIVIRAL THERAPY WITH SOFOSBUVIR PLUS RIBAVIRIN FOR THE TREATMENT OF SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 69
Outcomes of Liver Transplantation in Simultaneously Hepatitis BSurface Antigen and Hepatitis C Virus RNA Positive Recipients: TheDeleterious Effect of Donor Hepatitis B Core Antibody Positivity 67
IMMUNOGENETIC FACTORS AFFECT SURVIVAL IN HCV-INFECTED LIVER TRANSPLANT RECIPIENTS 67
Oral Surgical Treatment of Patients With Chronic Liver Disease: Assessments of Bleeding and Its Relationship With Thrombocytopenia and Blood Coagulation Parameters 66
Two Combined Genetic Markers Identify Hepatitis C Recipients With a Lower Graft Survival From The Earliest Post-Transplant Period 62
Long-Term Outcome of Veno-Occlusive Disease After Liver Transplant: A Retrospective Single-Center Experience 62
Outcomes of Liver Transplantation from Hepatitis B CoreAntibody–Positive Donors in Viral Cirrhosis Patients: The PrevailingNegative Effect of Recipient Hepatitis C Virus Infection 59
Liver transplantation from active COVID-19 donors: A lifesaving opportunity worth grasping? 59
Early and Late Hepatitis B Reactivation after IFN- or DAA-based Therapy of Recurrent Hepatitis C in Anti-HBc-positive Liver Transplant Recipients 56
SOFOSBUVIR PLUS RIBAVIRIN IN HCV-INFECTED CIRRHOTIC PATIENTS AWAITING LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 54
HCV viremic donors with hepatic bridging fibrosis: Are we ready to use their livers in the era of direct-acting antivirals? 53
Urgent liver transplantation soon after recovery from COVID-19 in a patient with decompensated liver cirrhosis 53
Seroconversion After Coronavirus Disease 2019 Vaccination in Patients Awaiting Liver Transplantation: Fact or Fancy? 50
The hepatitis D virus in Italy. A vanishing infection, not yet a vanished disease 49
Reply to: Seroconversion after COVID-19 vaccination (LT-21-741) 46
Severe Passenger Lymphocyte Syndrome and Acute Rejection in ABO Compatible but non-Identical Liver Transplant Recipient from Hepatitis C Viremic Donor 43
Seroprevalence of Hepatitis E Virus in liver transplant patients in Turin, Italy. 17
Coronavirus disease 2019 (COVID-19) vaccination in patients with cirrhosis: Does it work? 6
Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS) 5
Solid non-lung organs from COVID-19 donors in seropositive or naive recipients: Where do we stand? 4
Early post-liver transplant use of direct-acting antivirals in naive and NS5A inhibitor-experienced HCV patients 2
Liver Transplantation in Hepatitis B/Hepatitis D (Delta) Virus Coinfected Recipients 2
Totale 3577
Categoria #
all - tutte 6330
article - articoli 0
book - libri 0
conference - conferenze 2097
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8427


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20185 0000 00 00 0005
2018/2019243 2152116 2310 1433 11384020
2019/2020337 10151350 1658 3929 29342321
2020/2021424 19271312 2126 3636 40386393
2021/2022952 60447051 118109 5457 5262142133
2022/20231141 10010775106 80203 71119 123531040
Totale 3577